CPHI — China Pharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $6.23m
- $9.16m
- $4.53m
Annual cashflow statement for China Pharma Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.87 | -3.4 | -3.97 | -3.08 | -4.74 |
| Depreciation | |||||
| Non-Cash Items | 0.115 | 0.01 | -0.016 | 0.03 | 0.456 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.03 | 0.052 | 0.878 | -0.404 | 1.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.042 | -0.25 | -0.41 | -0.7 | -0.466 |
| Capital Expenditures | -0.867 | -0.438 | -0.402 | -0.012 | -0.292 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.867 | -0.438 | -0.402 | -0.012 | -0.292 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.624 | 4.6 | -1.77 | 0.073 | 0.027 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.227 | 3.9 | -2.83 | -0.606 | -0.797 |